Pink SheetInspection reports recently posted on the US Food and Drug Administration’s website suggest that pharmaceutical manufacturers are finally getting the follow-up inspections that could clear their manuf
Pink SheetThe US Food and Drug Administration raised concerns about Lupin Limited ’s overall corporate quality system in an 11 June warning letter concerning the company’s Novel Laboratories Inc. facility in